Vir Biotechnology Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders
The previously announced date and time of the Annual Meeting,
Attending the Virtual Meeting as a Stockholder of Record
Vir Biotechnology’s stockholders of record as of
If you do not have your 16-digit control number, you will be able to access and listen to the Annual Meeting, but you will not be able to vote your shares or submit questions during the Annual Meeting. See caption below titled “Attending the Annual Meeting as a Guest.”
Attending the Annual Meeting as a Beneficial Owner
We have been advised by Broadridge Financial Solutions, Inc. that beneficial stockholders as of the Record Date (i.e. shares held in “street name” through an intermediary, such as a bank or broker), who want to be able attend the Annual Meeting can attend using the 16-digit control number found on the notice and instructions received from their broker or other nominee.
If you are attending the Annual Meeting as stockholder of record or registered beneficial owner, questions can be submitted by accessing the meeting center at http://www.virtualshareholdermeeting.com/VIR2020, entering your 16-digit control number. Instructions on how to participate in the Annual Meeting are posted at http://www.virtualshareholdermeeting.com/VIR2020.
Stockholders of record and registered beneficial owners will be able to vote their shares electronically during the Annual Meeting. Instructions on how to vote while participating in the Annual Meeting live via the Internet are posted at http://www.virtualshareholdermeeting.com/VIR2020.
Whether or not stockholders plan to virtually attend the Annual Meeting,
The proxy card included with any proxy materials previously distributed will not be updated to reflect the change in location and may continue to be used to vote shares in connection with the Annual Meeting.
Attending the Annual Meeting as a Guest
Guests may enter the Annual Meeting in “listen-only” mode by entering the Annual Meeting at http://www.virtualshareholdermeeting.com/VIR2020 and entering the information requested in the “Guest Login” section. Guests will not have the ability to vote or ask questions during the Annual Meeting.
List of Stockholders
A list of stockholders of record will be available during the Annual Meeting for inspection by stockholders of record for any purpose germane to the Annual Meeting at http://www.virtualshareholdermeeting.com/VIR2020.
Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting hepatitis B virus, influenza A, SARS-CoV-2, human immunodeficiency virus and tuberculosis. For more information, please visit www.vir.bio.
Head of Investor Relations
Source: Vir Biotechnology, Inc.